Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Treasury Shares: 2018-2024

Historic Treasury Shares for Protagonist Therapeutics (PTGX) over the last 4 years, with Dec 2024 value amounting to $844,708.

  • Protagonist Therapeutics' Treasury Shares rose 27.12% to $844,708 in Q4 2024 from the same period last year, while for Dec 2024 it was $844,708, marking a year-over-year increase of 27.12%. This contributed to the annual value of $844,708 for FY2024, which is 27.12% up from last year.
  • Latest data reveals that Protagonist Therapeutics reported Treasury Shares of $844,708 as of FY2024, which was up 27.12% from $664,491 recorded in FY2023.
  • Protagonist Therapeutics' 5-year Treasury Shares high stood at $844,708 for FY2024, and its period low was $405,972 during FY2021.
  • Its 2-year average for Treasury Shares is $754,600, with a median of $754,600 in 2023.
  • Data for Protagonist Therapeutics' Treasury Shares shows a peak YoY climbed of 27.12% (in 2024) over the last 5 years.
  • Over the past 3 years, Protagonist Therapeutics' Treasury Shares (Yearly) stood at $405,972 in 2021, then reached $664,491 in 2023, then grew by 27.12% to $844,708 in 2024.